Gå videre til innhold

Pressemelding -

PRESS RELEASE: A new study shows that Calanus® Oil intake antagonizes negative changes in gut microbiota due to obesity

A new preclinical study conducted by a research team from Uit- The Arctic University of Norway, shows that Calanus® Oil supplementation in obese mice prevents negative changes in microbiota. This has led to new theories about the mechanisms of action of Calanus® Oil.

Current evidence suggests that obesity and its comorbidities are intrinsically linked with unfavorable changes in the intestinal microbiome. Thus, in line with its anti-obesity effect, it was hypothesized that dietary supplementation with Calanus® Oil should counteract the obesity-related deleterious changes in the gut microbiota.

The mouse model of diet-induced obesity shares many of the same characteristics as human obesity and is used as an important tool for understanding the mechanisms involved in diseases related to the ‘western-diet’.

“The fact that Calanus® Oil supplementation shows a benefit in gut microbiota just adds to the list of benefits we have documented. And even more interestingly, these findings have provided more ideas about the mechanisms of action of Calanus® Oil”, says Head of Science in Calanus Alice Marie Pedersen, PhD.

The researchers expected to see higher levels of the receptor family PPARs in adipose tissue. PPARs are involved in amongst others, the oxidation of fat, but the levels were not changed in adipose tissue. This observation has led to a hypothesis that PPARs were upregulated primarily in metabolically active tissues, such as liver, heart and skeletal muscle, leading to increased fatty acid oxidation and thereby draining of fatty acids from white adipose tissue.

“Indeed, we have more and more data from both preclinical and clinical studies showing that several of the benefits from Calanus® Oil are associated with positive effects on the muscles”, concludes Dr. Pedersen.

For further information about Calanus® Oil please contact Head of Sales and Marketing Jan Erik Olsen on tel. +47 951 45 351 or by e-mail: jan.erik.olsen@calanus.no. Please also refer to the company's website: www.calanus.no.

Related links

Emner

Kategorier


Calanus As is a Norwegian biomarine company pioneering harvesting and utilization of the crustacean Calanus finmarchicus, and is well positioned to play a key role in industrialization of the entire value chain through its intellectual property rights. Calanus As develops functional health- and nutrition ingredients for humans and animals exclusively from this valuable raw material. The Company’s main product is Calanus® Oil, an ecologically sustainable marine oil for humans. Calanus® Oil has unique composition and has shown benefits like improved insulin sensitivity, reduced deposition of intra-abdominal fat and powerful anti-inflammatory effects.

Kontakter

Relatert innhold

  • PRESS RELEASE: A new clinical trial shows that daily intake of Calanus® Oil improves body composition

    A new study conducted by a research team from Leibniz Universität in Hannover, Germany, shows exciting synergistic effects on body composition when combining moderate physical activity with Calanus® Oil supplementation.
    134 healthy, untrained participants (96 women and 38 men, average age 59 years, average BMI 28) took part in the 12-week interventional study. The participants were divided int

  • PRESS RELEASE: First Review Article on Health Effects of Wax Ester Omega-3s

    A recent review article by Schots et al., published in Frontiers in Pharmacology, investigates how the different constituents of Calanus® Oil can contribute to the prevention of obesity-induced low-grade inflammation and the associated metabolic disturbances. Calanus® Oil is a natural oil derived from the 1-year copepod Calanus finmarchicus. In addition to having the unique wax ester form, Calanus

  • Norway files application to include Calanus Oil in Codex Alimentarius

    Norwegian Authorities, represented by the Norwegian Food Safety Authority, have submitted an application to the Codex Alimentarius Commission to include calanus oil in the Codex Standard (CODEX STAN 329-2017). Codex Alimentarius is a joint initiative from The Food and Agriculture Organization and World Health Organization, both organizations from the United Nations.
    Oil from Calanus finmarchicu

  • PRESS RELEASE: Calanus As invests in a new production facility

    The decision has been triggered by the Government's decision to open for commercial harvesting of Calanus finmarchicus and the increasing demand for the company's products.
    Tromsø, Norway, June 4, 2019.
    Calanus AS is a Norwegian biomarine company pioneering harvesting and utilization of the copepod Calanus finmarchicus. The company has developed the entire value chain for sustainable harvest

  • PRESS RELEASE: Norway opens for commercial harvesting of zooplankton

    Tromsø, Norway, April 1st 2019.
    The Norwegian Government has decided to open for commercial harvesting of Calanus finmarchicus, the small copepod that constitutes the largest renewable and harvestable resource in the Norwegian sea.
    Based on a precautionary approach, the quota has initially been set at 254 000 tons per year, which is significantly lower than the potential sustainable yield.<

  • Calanus AS certified by Friend of the Sea®

    Tromsø, Norway, December 11, 2020

    Friend of the Sea®, one of the leading global certification standards for products and services that respect and protect the marine environment, has certified Calanus AS for harvesting of the zooplankton Calanus finmarchicus and the products derived from this huge marine resource. Calanus AS can now display the Friend of the Sea® eco-friendly label on their